Cell Based Assay Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Consumables, Assay Kits, Reagents, Cell growth assay, Reporter gene assay, Immortalized cell lines, Stem cell lines, Primary cell lines, Others), By Application (ADME studies, Basic research, Predictive toxicology, Drug discovery, Other), By End-user (Diagnostic Centres, Hospitals, Biopharmaceutical companies, Contract research organizations) and Region Forecast 2020-2031

Cell-Based Assay Market size was valued at US$ 19.4 billion in 2024 and is expected to reach US$ 35.7 billion by 2031, growing at a significant CAGR of 9.1% from 2025-2031. The market is the analytical technique to determine the different parameters such as biochemical or cellular functions of a living cell. Cell-based Assay is used in the research of new drugs by using functional cells as diagnostic tools. The cell-based Assay is commonly used to measure motility, toxicity, cell proliferation, enzyme activity, and morphology in diagnostics and drug discovery.

The market is carried out in several therapeutic areas such as cancer, stem cells, immunology, and others. from Argos Soditic for developing its product portfolio. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities, and possible challenges to the key stakeholders operating in the market. An increase in the prevalence and incidence of chronic diseases such as cancer, and drug discovery, an increase in government expenditure, and a rise in the adoption of cell-based consumables by various organizations might fuel the market over the forecast period.

Moreover, the rise in demand for biological drugs, increase in the preference for toxicity screening in drugs, and reduction of cost associated with drug discovery are expected to boost the market. However, the lack of skilled professionals for conducting the cell-based assays, the high cost of the instruments, and stringent regulatory policies might hinder the growth of the market.